Aimee Donald, MBChB, PhD

Articles by Aimee Donald, MBChB, PhD

Aimee Donald, MBChB, PhD, on Making Progress With Gene Therapy in Lysosomal Storage Diseases

October 30th 2022

The pediatrician from Royal Manchester Children’s Hospital discussed how further research in Gaucher disease can benefit the field of rare lysosomal diseases as a whole.

Aimee Donald, MBChB, PhD, on Assessing PR001 in Children With Type 2 Gaucher Disease

ByAimee Donald, MBChB, PhD

October 26th 2022

The pediatrician from Royal Manchester Children’s Hospital discussed progress with the PROVIDE trial of PR001.

Aimee Donald, MBChB, PhD

Articles by Aimee Donald, MBChB, PhD

Aimee Donald, MBChB, PhD, on Making Progress With Gene Therapy in Lysosomal Storage Diseases

Aimee Donald, MBChB, PhD, on Assessing PR001 in Children With Type 2 Gaucher Disease

Latest Updated Articles

Trending on CGTlive®

BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again

Regeneron’s Gene Therapy DB-OTO Improves Speech Perception in Children With Otoferlin-Related Hearing Loss

FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program